Mabpharm Limited: O HKD
Exchange | Code | Listed | Last trade | Delisted | |
---|---|---|---|---|---|
HK Main | 02181 | 2019-05-31 |
CCASS holding changes from 2022-09-01 to 2022-09-02
Hit the "stake change" to see the holder's history.
Some data are hidden to fit your display. Rotate?
Row | CCASS ID | Name | Holding | Change | Stake % |
Stake Δ % |
Last holding |
|
---|---|---|---|---|---|---|---|---|
1 | B01695 | DAH SING SECURITIES LTD | 582,000 | 60,000 | 0.01 | 0.00 | 2022-09-02 | |
2 | B01130 | BOCI SECURITIES LTD | 374,383,680 | 30,000 | 9.08 | 0.00 | 2022-09-02 | |
3 | B01224 | MERRILL LYNCH FAR EAST LTD | 94,000 | 22,000 | 0.00 | 0.00 | 2022-09-02 | |
4 | B01118 | EAST ASIA SECURITIES CO LTD | 162,000 | 20,000 | 0.00 | 0.00 | 2022-09-02 | |
5 | B01700 | REALINK FINANCIAL TRADE LTD | 48,000 | 8,000 | 0.00 | 0.00 | 2022-09-02 | |
6 | B01826 | GF SECURITIES (HONG KONG) BROKERAGE LTD | 298,000 | 4,000 | 0.01 | 0.00 | 2022-09-02 | |
7 | C00100 | JPMORGAN CHASE BANK, NATIONAL | 74,000 | 2,000 | 0.00 | 0.00 | 2022-09-02 | |
8 | C00033 | BANK OF CHINA (HONG KONG) LTD | 10,452,500 | -6,000 | 0.25 | -0.00 | 2022-09-02 | |
9 | C00019 | THE HONGKONG AND SHANGHAI BANKING | 2,073,319,000 | -10,000 | 50.27 | -0.00 | 2022-09-02 | |
10 | B01955 | FUTU SECURITIES INTERNATIONAL | 18,646,000 | -130,000 | 0.45 | -0.00 | 2022-09-02 | |
10 | Total changed named holdings | 2,478,059,180 | 0 | 60.09 | 0.00 | |||
102 | Unchanged named holdings | 1,478,961,770 | 0 | 35.86 | 0.00 | |||
112 | Total named holdings | 3,957,020,950 | 0 | 95.95 | 0.00 | |||
2 | Unnamed Investor Participants | 8,000 | 0 | 0.00 | 0.00 | |||
114 | Total securities in CCASS | 3,957,028,950 | 0 | 95.95 | 0.00 | |||
Securities not in CCASS | 167,051,050 | 0 | 4.05 | 0.00 | ||||
Issued securities | 4,124,080,000 | 0 | 100.00 | 0.00 | 31-Aug-2022 |
Trades that settled in this date range
These data are not adjusted for splits or bonus issues during the period.
Trading date | 2022-08-31 |
Volume | 176,000 |
Turnover | 80,570 |
Average price | 0.458 |
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy